<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>SE-0-SE-29-2019-03715_1-282-43082</iati-identifier>
  <reporting-org ref="SE-0" secondary-reporter="0" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Exploration of East African Medicinal Herbs in the Search for Novel Antibacterial Agents</narrative>
   <narrative xml:lang="SV">Utforskning av &#xD6;stafrikanska Medicinska V&#xE4;xter is S&#xF6;kandet f&#xF6;r Nya Antibakteriella Medel</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Antimicrobial resistance has become a major threat to human health and development. As our currently used antibiotics lose efficiency, we risk rapidly increasing number of untreatable infections leading to an increased number of lethal cases, longer hospital stays, and related suffering and economic burden. Antibiotic resistance is expected to hit developing countries especially hard, with 90% of the lethal infections predicted to happen in Africa and Asia.This study aims to make use of East African indigenous knowledge to use natural resources in finding new ways to control bacterial infections. Following an ethnomedical survey, medicinal plants will be collected in Kenya and Tanzania. Their constituents will be isolated, and identified by NMR and MS analyses. The bioactivity and toxicity of the isolated constituents will be determined using bacterial and cell-based assays. The biochemical pathways targeted by the most promising bioactive substances will be identified by chemical genomics. Advanced NMR techniques will subsequently be used to identify the binding mode of the substances to their protein targets to support their development into drugs.Besides achieving high scientific goals, the project aims the multidisciplinary training of East African PhD students. It will support the economic development of East Africa by strategic knowledge transfer and by promoting patient safety on the use of&#xA0;plants as a result of the scientific investigation of ethnomedical practices.</narrative>
   <narrative xml:lang="SV">Som resultat av &#xF6;veranv&#xE4;ndningen av antibiotika blir fler och fler av dem verkningsl&#xF6;sa. Denna process kallas resistensutveckling och har p&#xE5; senare tid blivit ett snabbt v&#xE4;xande problem som kan leda till en pandemi, dvs mycket snabb spridning av obotbara bakteriella sjukdomar. Antibiotikaresistens kan komma att kosta miljontals m&#xE4;nniskors liv &#xE5;rligen, fr&#xE4;mst i utvecklingsl&#xE4;nder.I detta projekt kommer tv&#xE5; svenska, en tanzanisk och en kenyansk forskargrupp att samarbeta med det &#xF6;vergripande m&#xE5;let att bidra till utvecklingen av nya antibiotika. Vi kommer att unders&#xF6;ka naturl&#xE4;kemedel fr&#xE5;n &#xD6;stra Afrika genom att identifiera nya bioaktiva substanser som verkar p&#xE5; hittills ok&#xE4;nda mekanismer. I dialog med lokala nyckelpersoner med kunskap inom naturmedicin, kommer vi att identifiera v&#xE4;xter som kan f&#xF6;rv&#xE4;ntas inneh&#xE5;lla antibakteriella substanser, extrahera molekylerna som finns i dem, best&#xE4;mma deras struktur och antibakteriella aktivitet och toxicitet samt identifiera mekanismen de anv&#xE4;nder f&#xF6;r att attackera bakterier. Ett av v&#xE5;ra m&#xE5;l &#xE4;r att identifiera substanser som verkar p&#xE5; nya s&#xE4;tt, och som bakterier inte har utvecklat resistens mot.Under projektets g&#xE5;ng kommer vi &#xE4;ven att &#xF6;verf&#xF6;ra kunskap till Tanzania och Kenya genom att tr&#xE4;na tanzaniska och kenyanska studenter och doktorander i moderna kemiska och biologiska forskningsmetoder vid Uppsala universitet.&#xA0;Sammanfattningsvis f&#xF6;rv&#xE4;ntas projektet att ta tillvara p&#xE5; &#xF6;stafrikansk inhemsk kunskap inom naturl&#xE4;kemedel och identifiera nya bioaktiva substanser som verkar p&#xE5; hittills ok&#xE4;nda mekanismer med det &#xF6;vergripande m&#xE5;let att bidra till utvecklingen av ny antibiotika f&#xF6;r l&#xE4;kemedel.</narrative>
  </description>
  <participating-org ref="SE-0" role="1" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </participating-org>
  <participating-org ref="SE-29" role="3" type="10">
   <narrative xml:lang="EN">The Swedish Research Council</narrative>
  </participating-org>
  <participating-org ref="51000" role="4" type="80">
   <narrative xml:lang="EN">Uppsala universitet</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2020-01-01" type="1"></activity-date>
  <activity-date iso-date="2020-01-01" type="3"></activity-date>
  <contact-info>
   <organisation>
    <narrative xml:lang="EN">The Swedish Research Council</narrative>
   </organisation>
   <telephone>+46 8 546 44 000</telephone>
   <email>vetenskapsradet@vr.se</email>
   <website>www.vr.se</website>
   <mailing-address>
    <narrative xml:lang="EN">Box 1035, 101 38 Stockholm, Sweden</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="TZ" percentage="100">
   <narrative xml:lang="EN">Tanzania, United Republic of</narrative>
  </recipient-country>
  <sector code="430" percentage="100" vocabulary="2">
   <narrative xml:lang="EN">Other Multisector</narrative>
  </sector>
  <sector code="43082" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Research/scientific institutions</narrative>
  </sector>
  <tag code="9.5" vocabulary="3">
   <narrative xml:lang="EN">9.5 - Enhance scientific research, upgrade the technological capabilities of industrial sectors in all countries, in particular developing countries, including, by 2030, encouraging innovation and substantially increasing the number of research and development workers per 1&#xA0;million people and public and private research and development spending.</narrative>
   <narrative xml:lang="SV">9.5 - F&#xF6;rb&#xE4;ttra forskningen och industrisektorernas tekniska kapacitet i alla l&#xE4;nder, i synnerhet utvecklingsl&#xE4;nderna, bland annat genom att till 2030 uppmuntra innovation och v&#xE4;sentligt &#xF6;ka det antal personer som arbetar med forskning och utveckling per 1 miljon m&#xE4;nniskor liksom de offentliga och privata utgifterna f&#xF6;r forskning och utveckling.</narrative>
  </tag>
  <policy-marker code="5" significance="1" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention on Biological Diversity</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention to Combat Desertification</narrative>
  </policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation</narrative>
  </policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation</narrative>
  </policy-marker>
  <policy-marker code="2" significance="1" vocabulary="1">
   <narrative xml:lang="EN">Aid to Environment</narrative>
  </policy-marker>
  <policy-marker code="11" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disability</narrative>
  </policy-marker>
  <policy-marker code="10" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disaster Risk Reduction(DRR)</narrative>
  </policy-marker>
  <policy-marker code="1" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Gender Equality</narrative>
  </policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Participatory Development/Good Governance</narrative>
  </policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Reproductive, Maternal, Newborn and Child Health (RMNCH)</narrative>
  </policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Trade Development</narrative>
  </policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="D02" vocabulary="1"></default-aid-type>
  <default-tied-status code="4"></default-tied-status>
  <budget>
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-28"></period-end>
   <value currency="USD" value-date="2020-01-01">62498.6698806693</value>
  </budget>
  <budget>
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-28"></period-end>
   <value currency="USD" value-date="2021-01-01">56304.4398840353</value>
  </budget>
  <budget>
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-28"></period-end>
   <value currency="USD" value-date="2022-01-01">42374.7787658664</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-11-28"></transaction-date>
   <value currency="USD" value-date="2019-11-28">156981.3555557906</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-28"></transaction-date>
   <value currency="USD" value-date="2020-01-28">62498.6698806693</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-28"></transaction-date>
   <value currency="USD" value-date="2021-01-28">42228.0856053943</value>
  </transaction>
  <crs-add>
   <other-flags code="1" significance="1"></other-flags>
  </crs-add>
  <sida:contribution xmlns:sida="http://sida.se/ns/contribution#"></sida:contribution>
 </iati-activity>
</iati-activities>
